Want to see IN:AJOONI full AI Analyst Report?
Total Valuation
Ajooni Biotech Limited has a market cap or net worth of ₹623.52M. The enterprise value is ₹897.51.
Market Cap₹623.52M
Enterprise Value₹897.51
Share Statistics
Ajooni Biotech Limited has 172,243,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding172,243,590
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ajooni Biotech Limited’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 2.79%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)2.79%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee16.73M
Profits Per Employee396.50K
Employee Count109
Asset Turnover1.52
Inventory Turnover3.92
Valuation Ratios
The current PE Ratio of Ajooni Biotech Limited is 17.3. Ajooni Biotech Limited’s PEG ratio is -0.85.
PE Ratio17.3
PS Ratio1.01
PB Ratio2.02
Price to Fair Value2.02
Price to FCF-7.94
Price to Operating Cash Flow4.95
PEG Ratio-0.85
Income Statement
In the last 12 months, Ajooni Biotech Limited had revenue of 1.82B and earned 43.22M in profits. Earnings per share was 0.09.
Revenue1.82B
Gross Profit276.71M
Operating Income40.50M
Pretax Income57.38M
Net Income43.22M
EBITDA62.56M
Earnings Per Share (EPS)0.09
Cash Flow
In the last 12 months, operating cash flow was 135.46M and capital expenditures -117.15M, giving a free cash flow of 18.31M billion.
Operating Cash Flow135.46M
Free Cash Flow18.31M
Free Cash Flow per Share0.11
Dividends & Yields
Ajooni Biotech Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.11
52-Week Price Change-27.83%
50-Day Moving Average3.85
200-Day Moving Average4.23
Relative Strength Index (RSI)52.53
Average Volume (3m)354.25K
Important Dates
Ajooni Biotech Limited upcoming earnings date is Nov 6, 2026, Before Open (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 6, 2026
Ex-Dividend Date―
Financial Position
Ajooni Biotech Limited as a current ratio of 2.72, with Debt / Equity ratio of 29.37%
Current Ratio2.72
Quick Ratio1.28
Debt to Market Cap0.10
Net Debt to EBITDA2.77
Interest Coverage Ratio5.55
Taxes
In the past 12 months, Ajooni Biotech Limited has paid 14.16M in taxes.
Income Tax14.16M
Effective Tax Rate0.25
Enterprise Valuation
Ajooni Biotech Limited EV to EBITDA ratio is 32.25, with an EV/FCF ratio of -8.68.
EV to Sales1.11
EV to EBITDA32.25
EV to Free Cash Flow-8.68
EV to Operating Cash Flow-38.77
Balance Sheet
Ajooni Biotech Limited has ₹4.19M in cash and marketable securities with ₹177.63M in debt, giving a net cash position of -₹173.44M billion.
Cash & Marketable Securities₹4.19M
Total Debt₹177.63M
Net Cash-₹173.44M
Net Cash Per Share-₹1.01
Tangible Book Value Per Share₹1.89
Margins
Gross margin is 14.16%, with operating margin of 2.22%, and net profit margin of 2.37%.
Gross Margin14.16%
Operating Margin2.22%
Pretax Margin3.15%
Net Profit Margin2.37%
EBITDA Margin3.43%
EBIT Margin2.22%
Analyst Forecast
The average price target for Ajooni Biotech Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast78.39%
EPS Growth Forecast15.76%